Genetic epidemiology of dengue viruses in phase III trials of the CYD tetravalent dengue vaccine and implications for efficacy
This study defined the genetic epidemiology of dengue viruses (DENV) in two pivotal phase III trials of the tetravalent dengue vaccine, CYD-TDV, and thereby enabled virus genotype-specific estimates of vaccine efficacy (VE). Envelope gene sequences (n = 661) from 11 DENV genotypes in 10 endemic coun...
Main Authors: | Maia A Rabaa, Yves Girerd-Chambaz, Kien Duong Thi Hue, Trung Vu Tuan, Bridget Wills, Matthew Bonaparte, Diane van der Vliet, Edith Langevin, Margarita Cortes, Betzana Zambrano, Corinne Dunod, Anh Wartel-Tram, Nicholas Jackson, Cameron P Simmons |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2017-09-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/24196 |
Similar Items
-
Age specific differences in efficacy and safety for the CYD-tetravalent dengue vaccine
by: Wilder-Smith, Annelies, et al.
Published: (2016) -
Genetic epidemiology of dengue virus in phase III trials of the CYD tetravalent vaccine and implications for efficacy
by: Rabaa, MA, et al.
Published: (2017) -
Molecular identification of dengue virus binding protein on filopodia of vero cells
by: Aliyu, Isah Abubakar
Published: (2017) -
Moving forward with Takeda's live chimeric tetravalent dengue vaccine
by: Wilder-Smith, Annelies
Published: (2017) -
Development of MVA-d34 Tetravalent Dengue Vaccine: Design and Immunogenicity
by: Ramil R. Mintaev, et al.
Published: (2023-04-01)